Susquehanna International Group’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-14,900
| Closed | -$20.7K | – | 13594 |
|
|
2023
Q4 | $20.7K | Hold |
14,900
| – | – | ﹤0.01% | 11969 |
|
|
2023
Q3 | $20.9K | Buy |
+14,900
| New | +$22.5K | ﹤0.01% | 11589 |
|
|
2022
Q4 | – | Sell |
-21,100
| Closed | -$47K | – | 13932 |
|
|
2022
Q3 | $47K | Sell |
21,100
-33,800
| -62% | -$81.6K | ﹤0.01% | 12245 |
|
|
2022
Q2 | $114K | Sell |
54,900
-800
| -1% | -$1.98K | ﹤0.01% | 11349 |
|
|
2022
Q1 | $162K | Buy |
55,700
+11,600
| +26% | +$37.2K | ﹤0.01% | 11486 |
|
|
2021
Q4 | $142K | Buy |
44,100
+13,100
| +42% | +$44.7K | ﹤0.01% | 11857 |
|
|
2021
Q3 | $110K | Sell |
31,000
-19,400
| -38% | -$64.7K | ﹤0.01% | 12007 |
|
|
2021
Q2 | $160K | Sell |
50,400
-8,600
| -15% | -$27K | ﹤0.01% | 11804 |
|
|
2021
Q1 | $203K | Buy |
59,000
+22,600
| +62% | +$70.3K | ﹤0.01% | 11401 |
|
|
2020
Q4 | $92K | Buy |
36,400
+18,900
| +108% | +$41.2K | ﹤0.01% | 10534 |
|
|
2020
Q3 | $37K | Sell |
17,500
-1,600
| -8% | -$3.8K | ﹤0.01% | 10281 |
|
|
2020
Q2 | $43K | Buy |
19,100
+8,300
| +77% | +$21.3K | ﹤0.01% | 9790 |
|
|
2020
Q1 | $27K | Buy |
+10,800
| New | +$26.5K | ﹤0.01% | 9861 |
|
|
2017
Q3 | – | Sell |
-16,400
| Closed | -$181K | – | 9769 |
|
|
2017
Q2 | $181K | Buy |
16,400
+100
| +0.6% | +$932 | ﹤0.01% | 8365 |
|
|
2017
Q1 | $136K | Buy |
+16,300
| New | +$115K | ﹤0.01% | 8256 |
|
|
2016
Q4 | – | Sell |
-27,100
| Closed | -$138K | – | 10278 |
|
|
2016
Q3 | $138K | Sell |
27,100
-800
| -3% | -$4.78K | ﹤0.01% | 7812 |
|
|
2016
Q2 | $167K | Buy |
27,900
+5,800
| +26% | +$32.2K | ﹤0.01% | 7753 |
|
|
2016
Q1 | $101K | Buy |
22,100
+1,700
| +8% | +$7.57K | ﹤0.01% | 8424 |
|
|
2015
Q4 | $92K | Buy |
+20,400
| New | +$86.1K | ﹤0.01% | 8917 |
|
|
2015
Q2 | – | Sell |
-10,400
| Closed | -$31K | – | 10534 |
|
|
2015
Q1 | $31K | Sell |
10,400
-17,800
| -63% | -$58.3K | ﹤0.01% | 9227 |
|
|
2014
Q4 | $125K | Buy |
+28,200
| New | +$134K | ﹤0.01% | 9105 |
|
Other funds holding ENZ
RC
XT
KCM
GSC
Susquehanna International Group's ENZ Position: Q2 2025 in Review
Susquehanna International Group sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 60,041 shares — an estimated $22.2K sold.
Susquehanna International Group first reported a position in ENZ in Q2 2013 and held it in 32 quarters. The position peaked at $734K in Q2 2017. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.
- Susquehanna International Group reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
- Susquehanna International Group sold 60,041 Enzo Biochem, Inc. shares in Q2 2025, an estimated $22.2K.
- Susquehanna International Group first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 32 quarters.
- Susquehanna International Group's Enzo Biochem, Inc. position peaked at $734K in Q2 2017.
- 6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.